Description

2,6-Methano-4H-1,3-Benzoxazocine-4-Thione, 2,3,5,6-Tetrahydro-2,3-Dimethyl- is a specialized heterocyclic organic compound featuring a unique bridged benzoxazocine-thione structure. This compound serves as a valuable advanced pharmaceutical intermediate and a versatile chemical building block for research and development. It is primarily utilized by pharmaceutical R&D and fine chemical synthesis sectors for the development of novel active ingredients and complex molecular architectures.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Organic Synthesis Building Block: Used in constructing complex heterocyclic frameworks for medicinal chemistry and material science research.
• Agrochemical Research: Intermediate for developing new active ingredients in crop protection and pesticide formulations.
• Ligand and Catalyst Development: Serves as a scaffold for creating specialized ligands in coordination chemistry and catalytic processes.
• Academic and Industrial R&D: Employed in research laboratories for studying structure-activity relationships (SAR) and reaction mechanisms.
• Fine Chemical Production: Used in the multi-step synthesis of high-value, low-volume specialty chemicals.

Basic Information

Product Name	2,6-Methano-4H-1,3-Benzoxazocine-4-Thione, 2,3,5,6-Tetrahydro-2,3-Dimethyl-
CAS No.	855841-69-9
Molecular Formula	C₁₂H₁₅NOS
Molecular Weight	221.32 g/mol
Synonyms	2,3-Dimethyl-2,3,5,6-tetrahydro-2,6-methano-4H-1,3-benzoxazocine-4-thione; 2,3-Dimethyl-2,3,5,6-tetrahydro-4H-2,6-methano-1,3-benzoxazocine-4-thione; Tetrahydro-2,3-dimethyl-2,6-methano-4H-1,3-benzoxazocine-4-thione; 855841-69-9; Benzoxazocine thione derivative; Bridged benzoxazocine thione
EINECS	Contact for details

Quality Control

Our 2,6-Methano-4H-1,3-Benzoxazocine-4-Thione, 2,3,5,6-Tetrahydro-2,3-Dimethyl- is produced under a strict quality management system. Each batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency. We provide a detailed Certificate of Analysis (COA) with every shipment, which includes results from HPLC, NMR, and other relevant spectroscopic methods. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. For long-term storage, consider maintaining the material under an inert atmosphere to preserve stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.